Filing Flows › Nurix Therapeutics (NRIX) › Recalls, complaints & regulation

Nurix Therapeutics (NRIX): clinical trials

Nurix Therapeutics (NRIX) beyond its filings: 6 active clinical trials.

Nurix Therapeutics' latest quarter

Nurix Therapeutics, Q3 FY26: revenue $673M (85× year over year), operating margin 83.1%, net earnings $550M, operating cash flow $616M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Nurix Therapeutics have?

6 active studies on ClinicalTrials.gov, 1 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.